NPK (NPK)

$940M
Market Cap
28.3
P/E Ratio
0.52
Beta
0.72%
Dividend Yield
Piotroski 4/9Altman Z 8.4 SafeBeneish M -1.73 Flag (> −2.22)ROIC−WACC +0.3%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9, Altman Z 8.4. Beneish M-Score of -1.73 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency presents a modest spread, with ROIC at 8.4% barely exceeding the WACC of 8.1%, resulting in a narrow +0.3% margin that suggests limited value creation relative to cost of capital. Despite this tight economic moat, profitability drivers remain robust as net margins sit at 6.6% and gross margins expand to 16.0%. However, earnings quality indicators reveal mixed signals; the Piotroski F-Score of 4/9 indicates a lack of financial strength improvements compared to peers, while the Altman Z-Score of 8.4 points to low bankruptcy risk. Conversely, the Beneish M-Score of -1.73 strongly suggests that earnings are unlikely to be manipulated, offering some reassurance regarding reported performance despite the mediocre Piotroski rating.

Valuation metrics reflect aggressive market pricing relative to historical norms and sector benchmarks, with a current P/E ratio of 28.3x implying significant growth expectations embedded in shares. This premium appears justified only if revenue expansion sustains its impressive YoY trajectory of 29.7%, as the narrow ROIC-WACC spread leaves little room for error before returns deteriorate below capital costs. The disconnect between high top-line momentum and stagnant capital efficiency metrics creates a scenario where multiple compression could occur rapidly should growth rates decelerate even slightly, potentially eroding shareholder value given the current valuation floor.

The risk profile is characterized by a divergence between solvency stability and operational leverage; while balance sheet health appears secure per Altman standards, the inability to generate returns materially above the cost of capital limits downside protection during market stress. Investors must weigh whether the 29.7% revenue growth can translate into improved ROIC before earnings quality concerns or margin compression impact stock performance. The data suggests a high-beta opportunity where upside relies entirely on sustaining hyper-growth, while any slowdown exposes the thin valuation cushion inherent in the current multiple structure.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
8.4
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-1.73
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

16.0%
Gross Margin
6.6%
Net Margin
8.4%
ROIC
8.1%
WACC
ROIC − WACC Spread: +0.3%— Positive spread.
+29.7%
Revenue Growth (YoY)
-20.2%
Earnings Growth (YoY)
-36.2M
Free Cash Flow

Balance Sheet Health

0.27x
Debt / Equity
4.25x
Current Ratio
0.1x
Net Debt / EBITDA
-3.83%
FCF Yield
48.1M
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $1.72
Act: $0.60
-65.1%
Q3
✗ Miss
Est: $1.12
Act: $0.74
-34.2%
Q2
✓ Beat
Est: $1.50
Act: $1.80
+20.2%
Q1
✓ Beat
Est: $0.99
Act: $1.17
+18.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

150.7
Forward P/E
PEG Ratio
2.36
Price/Book
83957
Avg Volume
$149.86
52W High
$77.63
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$33M
Tracked Passive Exposure
7
ETFs Holding NPK
0.07%
Avg Weight in ETFs
$45B
Total ETF AUM

When investors buy or sell ETFs like XAR or SLYG, the fund manager is mechanically forced to buy or sell NPK shares regardless of NPK's individual fundamentals. We estimate $33M of passive capital is structurally linked to NPK through 7 tracked ETFs. Passive flows have a limited but growing influence on NPK's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 7 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in NPK to visualize passive redemption contagion across ETFs and collateral stocks.

NPK Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
NPKEpicenterSPSMETFSPTMETFVISETFRKLBLow RiskMRCYUnknownCRSLow RiskCWLow RiskVSECLow Risk
NPK Price Drop (%)0

If NPK (NPK) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ROCKET LAB CORP (RKLB) as the most exposed collateral stock, sharing 1 ETFs with NPK. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 7 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

NPK Ownership Dynamics

Ticker
NPK

Float lock-up computed from 7 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

NPK Capital Efficiency

How efficiently does NPK convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$-36,171,000
EBITDA
$48M
FCF Conversion
-75%
Reinvestment Rate
175%
-75% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
8.4%
ROIC − WACC Spread
0.3%

NPK converts -75% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 175% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 0.3% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-04-2968$146.54$9,964.72
2026-04-1060$142.97$8,578.2
2026-04-061,531$141.65$216,866.15
2026-04-021,531$141.89$217,233.59
2026-04-011,531$137.06$209,838.86
2026-03-18957$134.76$128,965.32
2026-03-17448$139.38$62,442.24
2026-02-2455$127.36$7,004.8
2026-02-201$127.05$127.05
2026-02-0317$131.95$2,243.15
2025-12-26160$109.76$17,561.6
2025-12-1624$104.93$2,518.32
2025-12-1068$101.00$6,868
2025-11-06128$107.86$13,806.08

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare NPK to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.